- Researchers have designed a blood test for cancer that looks at the methylation of cell-free DNA.
- A large-scale trial is ongoing to determine how the Gallieri test, as it is known, influences the time to cancer diagnosis.
- Some results from the trial were recently presented at a conference.
- They show a high rate of false positives but a low rate of false negatives.
By Hannah Flynn on September 16, 2022
Fact checked by Ferdinand Lali, Ph.D.
Call us at (888)-243-6602 to discuss how we can help keep your loved one safe and happy at home.